Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000553
Filing Date
2024-12-23
Accepted
2024-12-23 16:40:19
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3845
  Complete submission text file 0001610717-24-000553.txt   5301
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Issuer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010
Business Address
Arcara Jeffrey (Reporting) CIK: 0002010430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37719 | Film No.: 241574272